ut this deal sure seems likely to improve Pfizer's access to physicians, which, if typical of the industry as a whole, has been waning due to physician push back and state laws limiting free gifts to physicians, among other reasons.At the core of the agreement between Pfizer and Sermo is the only form of free gift to physicians that Pfizer and other drug companies have left to give: drug treatment